| Title |
Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non–Small Cell Lung Cancer
|
|---|---|
| Published in |
Cancer Discovery, February 2021
|
| DOI | 10.1158/2159-8290.cd-20-1683 |
| Pubmed ID | |
| Authors |
Francois Gonzalvez, Sylvie Vincent, Theresa E. Baker, Alexandra E. Gould, Shuai Li, Scott D. Wardwell, Sara Nadworny, Yaoyu Ning, Sen Zhang, Wei-Sheng Huang, Yongbo Hu, Feng Li, Matthew T. Greenfield, Stephan G. Zech, Biplab Das, Narayana I. Narasimhan, Tim Clackson, David Dalgarno, William C. Shakespeare, Michael Fitzgerald, Johara Chouitar, Robert J. Griffin, Shengwu Liu, Kwok-kin Wong, Xiaotian Zhu, Victor M. Rivera |
X Demographics
The data shown below were collected from the profiles of 51 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 24 | 47% |
| France | 3 | 6% |
| United Kingdom | 3 | 6% |
| Italy | 2 | 4% |
| Turkey | 1 | 2% |
| Spain | 1 | 2% |
| India | 1 | 2% |
| Unknown | 16 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 29 | 57% |
| Scientists | 11 | 22% |
| Practitioners (doctors, other healthcare professionals) | 7 | 14% |
| Science communicators (journalists, bloggers, editors) | 4 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 92 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 11 | 12% |
| Researcher | 11 | 12% |
| Other | 10 | 11% |
| Student > Bachelor | 4 | 4% |
| Student > Doctoral Student | 2 | 2% |
| Other | 7 | 8% |
| Unknown | 47 | 51% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 12% |
| Medicine and Dentistry | 11 | 12% |
| Biochemistry, Genetics and Molecular Biology | 9 | 10% |
| Chemistry | 6 | 7% |
| Agricultural and Biological Sciences | 3 | 3% |
| Other | 4 | 4% |
| Unknown | 48 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 178. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 January 2022.
All research outputs
#216,052
of 24,716,872 outputs
Outputs from Cancer Discovery
#79
of 3,952 outputs
Outputs of similar age
#6,480
of 425,110 outputs
Outputs of similar age from Cancer Discovery
#5
of 162 outputs
Altmetric has tracked 24,716,872 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,952 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 425,110 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 162 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.